
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Journal
- Events
- Suppliers
Suppliers
- Home
- Industry news
Industry news
- Category news
- Reports
- Key trends
- Multimedia
Multimedia
- Events
- Suppliers
Suppliers
DolCas Biotech: CEO highlights Morikol marine collagen science and delivery format R&D
25 Jun 2026 | DolCas Biotech
KG Rao, CEO of DolCas Biotech, dives deeper into the science behind Morikol, its marine collagen tripeptide ingredient. He also shares market insights on marine collagen and highlights DolCas Biotech’s R&D strategy, which focuses on delivery format developments. For example, DolCas Biotech recently released a “melt-in-your-mouth” powder in sachet form to support convenience.
Upcoming webinars

Bifidobacteria and Healthy Ageing: New Insights into Ageing and Immunity
Morinaga

The future of infant nutrition: From science to success
Valio

From tiny guts to big impact: the powerful potential of probiotics in children’s health
Novonesis
















